#1 Clinical Trials Search in Europe

Pregabalin

This article examines the use of pregabalin (also known by the brand name Lyrica) in clinical trials for various medical conditions. Pregabalin is being studied for its effectiveness in treating conditions like restless legs syndrome, postoperative pain, epilepsy, and neuropathic pain. The trials aim to assess pregabalin’s efficacy, optimal dosing, pharmacokinetics, and safety profile compared to placebos or other treatments.

Table of Contents

What is Pregabalin?

Pregabalin, also known by the brand name Lyrica, is a medication used to treat various neurological and pain conditions. It belongs to a class of drugs called alpha-2 delta ligands[1]. Pregabalin was developed to help patients who may not respond well to other treatments, offering an alternative option for managing certain types of pain and seizures.

Conditions Treated with Pregabalin

Pregabalin is approved to treat several conditions, including:

  • Neuropathic pain: This includes pain caused by diabetes (diabetic neuropathy) and pain that occurs after shingles (postherpetic neuralgia)[2][3]
  • Fibromyalgia: A condition characterized by widespread muscle pain and tenderness[4]
  • Epilepsy: Specifically for partial onset seizures in adults and children (4 years and older)[5]
  • Generalized anxiety disorder: In some countries, pregabalin is approved for this condition

How Pregabalin Works

Pregabalin works by binding to certain areas in the brain and nervous system. This action helps to reduce the release of neurotransmitters (chemical messengers) involved in pain signaling and seizure activity. By doing so, pregabalin can help decrease pain sensations and reduce the frequency of seizures in people with epilepsy[1].

Dosage and Administration

Pregabalin is available in various forms and dosages:

  • Capsules: Usually ranging from 25 mg to 300 mg
  • Oral solution: For patients who have difficulty swallowing capsules

The dosage of pregabalin varies depending on the condition being treated, the patient’s age, and other factors. For example:

  • For adults with neuropathic pain, the typical starting dose is 150 mg per day, which may be increased up to 300 mg per day[1]
  • For children with epilepsy, the dose is usually based on body weight, ranging from 2.5 mg/kg/day to 10 mg/kg/day, with a maximum of 600 mg per day[6]

Pregabalin is usually taken in divided doses, either twice or three times daily. It’s important to follow your doctor’s instructions carefully and not to adjust the dose without consulting them first.

Efficacy of Pregabalin

Clinical trials have shown pregabalin to be effective in treating various conditions:

  • Neuropathic pain: Studies have demonstrated that pregabalin can significantly reduce pain scores in patients with diabetic neuropathy and postherpetic neuralgia[3]
  • Fibromyalgia: Pregabalin has been shown to improve pain scores, sleep quality, and overall quality of life in patients with fibromyalgia[4]
  • Epilepsy: In children and adults with partial onset seizures, pregabalin has been effective in reducing seizure frequency[5][7]

Side Effects and Safety Considerations

Like all medications, pregabalin can cause side effects. Common side effects may include:

  • Dizziness
  • Drowsiness
  • Dry mouth
  • Blurred vision
  • Weight gain
  • Difficulty concentrating

More serious side effects, although rare, can include:

  • Allergic reactions
  • Suicidal thoughts or behaviors
  • Swelling of the hands, feet, or ankles
  • Muscle pain or weakness

It’s important to report any side effects to your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation[6].

Use in Special Populations

Pregabalin has been studied in various age groups:

  • Children: It is approved for use in children 4 years and older for partial onset seizures. The dosage is typically based on body weight[5]
  • Elderly: Older adults may be more sensitive to the effects of pregabalin and may require lower doses
  • Pregnancy and breastfeeding: The safety of pregabalin during pregnancy and breastfeeding is not well established. It’s important to discuss the potential risks and benefits with your doctor if you are pregnant, planning to become pregnant, or breastfeeding

Monitoring During Treatment

While taking pregabalin, your healthcare provider may recommend regular check-ups to monitor your progress and any potential side effects. This may include:

  • Regular assessments of pain levels or seizure frequency
  • Monitoring of mood changes, especially in patients with a history of depression
  • Blood tests to check kidney function, especially in older adults or those with kidney problems
  • Vision tests, as pregabalin can sometimes affect eyesight[8]

It’s crucial to attend all scheduled appointments and to inform your doctor of any changes in your symptoms or the occurrence of side effects.

Aspect Details
Conditions Studied Restless Legs Syndrome, Postoperative Pain, Partial Seizures, Peripheral Neuropathic Pain, Catheter-Related Bladder Discomfort
Dosage Forms Oral capsules, tablets (immediate release and controlled release)
Dose Ranges 50mg to 600mg daily
Primary Outcomes Changes in pain scores, seizure frequency, sleep quality, pharmacokinetic parameters
Secondary Outcomes Quality of life measures, anxiety/depression scores, patient global impression of change
Safety Monitoring Adverse events, vital signs, laboratory tests, ECG changes, suicidal ideation
Comparison Groups Placebo, immediate release vs. controlled release formulations
Study Designs Randomized, double-blind, placebo-controlled, crossover trials

FAQ

  • What medical conditions is pregabalin being studied for in these clinical trials? Pregabalin is being studied for several conditions including restless legs syndrome, postoperative pain, partial seizures in epilepsy, peripheral neuropathic pain, and catheter-related bladder discomfort.
  • How is pregabalin typically administered in these trials? Pregabalin is usually given orally in capsule or tablet form. Dosages and frequency vary by study, ranging from 50mg to 600mg per day, sometimes in single daily doses and other times split into multiple doses.
  • What are some of the main outcomes being measured in pregabalin trials? Common outcomes include changes in pain scores, seizure frequency, sleep quality, anxiety and depression levels, and quality of life measures. Studies also assess pharmacokinetics, optimal dosing, and side effects.
  • How does pregabalin compare to placebos in the trials? While specific results aren't provided, pregabalin is being compared to placebos in several studies to determine its effectiveness for conditions like restless legs syndrome and partial seizures.
  • What are some potential side effects of pregabalin being monitored? Side effects being monitored include dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and changes in mood or suicidal thoughts. Studies are assessing both the frequency and severity of adverse events.

Ongoing Clinical Trials on Pregabalin

  • Comparison of Pregabalin and Baclofen Treatment in Patients with Spastic Motor Behavior Following Cervical or Thoracic Spinal Cord Injury

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Title: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effectiveness and Safety of VX-993 and Pregabalin for Pain Relief in Patients with Diabetic Peripheral Neuropathy

    Recruiting

    2 1 1
    Investigated drugs:
    France Germany Italy

  • Study on the Effects of Ketorolac and Pregabalin in Patients Undergoing Surgery for Early Estrogen Receptor-Positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated drugs:
    Belgium

  • Study on the Effects of Vortioxetine on Cognitive Function in Patients with Early Schizophrenia

    Recruiting

    4 1 1 1
    Investigated drugs:
    Spain

  • Study on Reducing Oral Side Effects of Talquetamab in Multiple Myeloma Patients Using Pregabalin, Dexamethasone, and Clonazepam

    Recruiting

    2 1 1 1
    Investigated drugs:
    The Netherlands Spain

  • Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

  • Study on Dexamethasone for Patients with Moderate to Severe Depression: Evaluating Its Effectiveness with Mirtazapine, Citalopram, and Nortriptyline

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Reducing Antipsychotic Dose vs. Maintenance Treatment for Patients with Schizophrenia Using Haloperidol Decanoate, Risperidone, and Amisulpride

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Study on the Effect of Pregabalin on Sleep and Pain in Patients with Neuropathic Pain

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Pregabalin: An anticonvulsant medication also used to treat nerve pain. It's being studied for various conditions and is known by the brand name Lyrica.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Restless Legs Syndrome (RLS): A condition characterized by an uncomfortable sensation and urge to move the legs, often occurring at night.
  • Neuropathic Pain: Pain caused by damage or disease affecting the nervous system.
  • Partial Seizures: A type of epileptic seizure that starts in one area of the brain.
  • Catheter-Related Bladder Discomfort (CRBD): Discomfort or urge to urinate caused by irritation from a urinary catheter.
  • GLARS (Geometrically Long Absorption Regulated System): A drug delivery system designed to extend the absorption of a medication in the body.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, used in pharmacokinetic studies.
  • Cmax: The maximum concentration of a drug in the blood after dosing.
  • Visual Analog Scale (VAS): A measurement tool used to assess subjective characteristics like pain intensity.

References

  1. https://clinicaltrials.gov/study/NCT00599638
  2. https://clinicaltrials.gov/study/NCT00424372
  3. https://clinicaltrials.gov/study/NCT01057693
  4. https://clinicaltrials.gov/study/NCT01773993
  5. https://clinicaltrials.gov/study/NCT01389596
  6. https://clinicaltrials.gov/study/NCT01463306
  7. https://clinicaltrials.gov/study/NCT01747915
  8. https://clinicaltrials.gov/study/NCT00351611